Company
Headquarters: Baotou, China
Employees: 715
CN¥3.48 Billion
CNY as of Jan. 1, 2025
US$477.4 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Baotou Dongbao Bio-Tech Co., Ltd. engages in the research and development, production, and sale of gelatin and collagen products in the People's Republic of China and internationally. It offers food additive and pharmaceutical gelatin, as well as collagen peptide. The company was founded in 1997 and is based in Baotou, the People's Republic of China.
Baotou Dongbao Bio-Tech Co.,Ltd has the following listings and related stock indices.
Stock: SZSE: 300239 wb_incandescent